Preliminary results of a phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology (NSCLC-NS) with disease progression after a bevacizumab (bev) containing therapy.
Thomas E. Stinchcombe
Research Funding - GlaxoSmithKline
Jared Weiss
No relevant relationships to disclose
Liza Cosca Villaruz
No relevant relationships to disclose
Anastasia Ivanova
No relevant relationships to disclose
Juneko E. Grilley-Olson
Research Funding - Bayer; GlaxoSmithKline; Kyowa Hakko Kirin; Novartis; ZIOPHARM Oncology
Nirav Suresh Dhruva
No relevant relationships to disclose
Mark A. Socinski
No relevant relationships to disclose